Fludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects
New Delhi: Noting the possible risk of expected adverse effects in healthy subjects, the Subject Expert Committee (SEC), functioning under the Central Drug Standard Control Organization (CDSCO), has declined to recommend a proposed clinical study by Advity Research Private Limited for Fludrocortisone Tablets USP 0.2 mg. This came after the firm presented the protocol along […]